Needs of cancer patients during the SARS-CoV-2 Omicron lockdown: A population-based survey in Shanghai, China

被引:5
|
作者
Chen, Minxing [1 ]
Li, Ruijia [1 ]
Ding, Gang [2 ]
Jin, Chunlin [1 ]
机构
[1] Shanghai Med Informat Ctr, Shanghai Hlth Dev Res Ctr, Jianguo W Rd 602, Shanghai 200031, Peoples R China
[2] Shanghai Int Med Ctr, Oncol Dept, Shanghai, Peoples R China
关键词
Shanghai lockdown; SARS-CoV-2; Omicron; cancer patients; needs; COVID-19 VACCINE REFUSAL; ITALY EARLY DATA; 1ST REPORT; DISEASE;
D O I
10.5582/bst.2022.01251
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The aim of this study was to investigate the medical and healthcare needs of cancer patients during the Shanghai lockdown due to the SARS-CoV-2 Omicron pandemic. From April 15 to April 21, 2022, 4,195 cancer patients from every district in Shanghai were surveyed using quota sampling via an online platform. The questionnaire consisted of three main parts: demographic and sociological data, disease diagnosis, and different dimensions of patients' needs. Correlation analysis was used to examine the relationship between participants' need scores in each dimension, and generalized linear regression models were used to analyze the factors influencing patients' need scores. The mean age of participants was 63.23 years (SD: 7.43 years), with more female than male participants (80.38% vs. 19.62%). Among participants, the three leading groups of patients were those with breast cancer (39.02%), colorectal cancer (12.82%), or tracheal and bronchial lung cancer (10.23%). Social support, dietary/ nutritional support, and psychological counselling ranked as the top three needs of cancer patients. In addition, vaccination against SARS-CoV-2 may reduce psychological anxiety in cancer patients. Compared to participants who had never received the SARS-CoV-2 vaccine, participants who had received one, two, or three doses of the vaccine were respectively 36% (odds ratio (OR): 0.64, 95% confidence interval (CI): 0.56-0.73), 38% (OR: 0.62, 95% CI: 0.59-0.54), and 37% (OR: 0.63, 95% CI: 0.60-0.66) less likely to have an increased need for psychological counseling. In light of constraints on offline medical resources for cancer patients during the lockdown, the current authors have begun to re-examine the universal accessibility and spread of telemedicine in the future. In addition, immune barriers can be established for cancer patients and vaccination guidelines for different disease stages, tumor types, and treatment regimens can be explored in detail.
引用
收藏
页码:230 / 237
页数:8
相关论文
共 50 条
  • [31] What Really Happened During the Massive SARS-CoV-2 Omicron Wave in China?
    Ioannidis, John P. A.
    Zonta, Francesco
    Levitt, Michael
    JAMA INTERNAL MEDICINE, 2023, 183 (07) : 633 - 634
  • [32] Mortality and Hospitalization Risks in Patients With Cancer and the SARS-CoV-2 Omicron Variant
    Ofer, Jonathan
    Drozdinsky, Genady
    Basharim, Bar
    Turjeman, Adi
    Eliakim-Raz, Noa
    Stemmer, Salomon M.
    JAMA ONCOLOGY, 2024, 10 (01) : 137 - 138
  • [33] SARS-CoV-2 and the perspectives of people living with cancer: The AIIAO survey on the Italian lockdown
    Biagioli, V.
    Belloni, S.
    Albanesi, B.
    Piredda, A.
    Caruso, R.
    ANNALS OF ONCOLOGY, 2020, 31 : S1137 - S1138
  • [34] Effect of Lockdown and Mass Testing for the SARS-CoV-2 Omicron Epidemic on Reducing New Infections in Shenzhen, China
    Han, Xinxin
    Li, Xiaotong
    Zhu, Bin
    Zhao, Wenjing
    Huang, Jie
    Liu, Gang
    Gu, Dongfeng
    HEALTHCARE, 2022, 10 (09)
  • [35] Oral Habits during the Lockdown from the SARS-CoV-2 Pandemic in the Romanian Population
    Caramida, Mariana
    Dumitrache, Mihaela Adina
    Tancu, Ana Maria Cristina
    Ilici, Roxana Romanita
    Ilinca, Radu
    Sfeatcu, Ruxandra
    MEDICINA-LITHUANIA, 2022, 58 (03):
  • [36] Severe SARS-CoV-2 infection as a marker of undiagnosed cancer: a population-based study
    Adeline Dugerdil
    Laura Semenzato
    Alain Weill
    Mahmoud Zureik
    Antoine Flahault
    Scientific Reports, 13
  • [37] Prevalence and determinants of SARS-CoV-2 vaccine hesitancy in Hong Kong: A population-based survey
    Luk, Tzu Tsun
    Zhao, Shengzhi
    Wu, Yongda
    Wong, Janet Yuen-ha
    Wang, Man Ping
    Lam, Tai Hing
    VACCINE, 2021, 39 (27) : 3602 - 3607
  • [38] Severe SARS-CoV-2 infection as a marker of undiagnosed cancer: a population-based study
    Dugerdil, Adeline
    Semenzato, Laura
    Weill, Alain
    Zureik, Mahmoud
    Flahault, Antoine
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [39] Epidemiological characteristics of paediatric Omicron infection during the outbreak of SARS-CoV-2 infection during March-May in 2022 in Shanghai, China
    Chang, Hailing
    Zhang, Xuanzhao
    Su, Hualin
    Cai, Jiehao
    Liu, Xiaohua
    Li, Jingjing
    Wang, Yating
    Zhang, Zhaowen
    Zhu, Minghui
    Zhao, Lifang
    Zhang, Sijia
    Mei, Kewen
    Zhang, Liping
    Wang, Xiaoguang
    Yan, Hongjin
    Luo, Lingfei
    Xu, Zhiyin
    Zeng, Mei
    EPIDEMIOLOGY AND INFECTION, 2023, 151
  • [40] Prevalence of SARS-CoV-2 antibodies in the State of Mato Grosso, Brazil: a population-based survey
    de Oliveira, Elaine Cristina
    Pereira Tercas-Trettel, Ana Claudia
    de Souza Andrade, Amanda Cristina
    Muraro, Ana Paula
    dos Santos, Emerson Soares
    Espinosa, Mariano Martinez
    De Musis, Carlo Ralph
    CADERNOS DE SAUDE PUBLICA, 2022, 38 (05):